ZKSCAN3 and neoplasm: miR-124 is widely recognized for its role in suppressing epithelial-mesenchymal transition (EMT) and maintaining epithelial integrity, and its targeting of ZKSCAN3 implies a mechanism by which it can inhibit tumor progression and metastasis by reducing ZKSCAN3-mediated oncogenic activities.